Publications (225) LUIS FELIPE CALLADO HERNANDO publications

filter_list

2026

  1. Brain and circulating EV proteome signatures in schizophrenia as prognostic markers for age-related dementia

    Acta Neuropathologica Communications , Vol. 14, Núm. 1

  2. Extracellular matrix dysfunction and synaptic alterations in schizophrenia

    Molecular Psychiatry, Vol. 31, Núm. 1, pp. 396-406

2025

  1. A method for HDAC activity screening in postmortem human brain. A proof-of-concept study with antipsychotics

    Journal of Neuroscience Methods, Vol. 416

  2. A molecular convergence in the triad of parkinson’s disease, depressive disorder and gut health is revealed by the inflammation-miRNA axis

    Journal of Neuroinflammation , Vol. 22, Núm. 1

  3. Altered immune and inflammatory gene expression in prefrontal cortex of antipsychotic-free schizophrenia subjects

    Brain, Behavior, and Immunity - Health, Vol. 49

  4. Assessment of risk factors associated with methadone-induced deaths: A population study based on forensic autopsies (2003–2022)

    Forensic Science International, Vol. 376

  5. Association of astrocyte-specific gene expression in the dorsolateral prefrontal cortex with clozapine treatment in schizophrenia

    Translational Psychiatry, Vol. 15, Núm. 1

  6. Discovery of (3-Phenylcarbamoyl-3,4-dihydro-2H-pyrrol-2-yl)phosphonates as Imidazoline I2 Receptor Ligands with Anti-Alzheimer and Analgesic Properties

    Journal of Medicinal Chemistry, Vol. 68, Núm. 3, pp. 2551-2573

  7. Distinctive patterns of G protein coupling induced by the structurally similar 5-HT2Areceptor ligands ketanserin and altanserin in human prefrontal cortex

    Molecular Pharmacology, Vol. 107, Núm. 11

  8. Efectos terapéuticos de los componentes del cannabis

    FMC: Formación Médica Continuada en Atención Primaria, Vol. 32, Núm. 6, pp. 316-323

  9. Fármacos antidepresivos y antimaniacos

    Velázquez, farmacología básica y clínica (Editorial Médica Panamericana), pp. 315-328

  10. Impaired unfolded protein response, BDNF and synuclein markers in postmortem dorsolateral prefrontal cortex and caudate nucleus of patients with depression and Parkinson's disease

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 138

  11. Receptor-mediated Gi-3 activation in mammalian and human brain membranes: Reestablishment method and its application to nociceptin/orphanin FQ opioid peptide (NOP) receptor/Gi-3 interaction

    Journal of Pharmacological Sciences, Vol. 158, Núm. 2, pp. 131-138

  12. Regional profiling reveals a distinct glioblastoma infiltrative margin proteome

    Scientific Reports, Vol. 15, Núm. 1

  13. Synthesis of Diversely Substituted Diethyl (Pyrrolidin-2-Yl)Phosphonates

    Molecules, Vol. 30, Núm. 9

2024

  1. Alcohol Triggers the Accumulation of Oxidatively Damaged Proteins in Neuronal Cells and Tissues

    Antioxidants, Vol. 13, Núm. 5

  2. Effect of antipsychotic drugs on group II metabotropic glutamate receptor expression and epigenetic control in postmortem brains of schizophrenia subjects

    Translational Psychiatry, Vol. 14, Núm. 1

  3. Effects of cannabidiol in post-stroke mood disorders in neonatal rats

    Pediatric Research, Vol. 95, Núm. 7, pp. 1783-1790

  4. Exploring the reactivity of bicyclic α-iminophosphonates to access new imidazoline I2 receptor ligands

    Bioorganic Chemistry, Vol. 142

  5. High number of mitochondrial DNA alterations in postmortem brain tissue of patients with schizophrenia compared to healthy controls

    Psychiatry Research, Vol. 337